Kodiak sciences inc. (KOD)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Dec'17
Assets
Current assets:
Cash and cash equivalents

226,456

211,797

37,033

44,967

57,222

88,254

11,590

1,395

Marketable securities

195,404

124,684

23,571

23,134

23,853

-

-

-

Prepaid expenses and other current assets

2,947

2,749

440

2,391

2,202

2,195

703

200

Total current assets

424,807

339,230

61,044

70,492

83,277

90,449

12,293

1,595

Marketable securities

8,533

11,696

-

-

-

-

-

-

Restricted cash

140

140

140

140

140

140

140

140

Property and equipment, net

1,056

996

1,114

1,238

1,084

1,097

1,198

1,509

Operating lease right-of-use asset

1,692

1,790

1,887

1,981

2,073

-

-

-

Other assets

6,814

5,014

4,731

4,424

503

503

-

-

Deferred offering costs

-

-

-

-

-

-

3,484

-

Total assets

443,042

358,866

68,916

78,275

87,077

92,189

17,115

3,244

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable

4,506

2,619

1,670

2,529

1,754

1,050

1,724

3,356

Accrued and other current liabilities

8,880

8,658

5,210

3,277

2,628

3,776

3,659

5,802

Operating lease liability

448

434

421

408

391

-

-

-

Total current liabilities

13,834

11,711

7,301

6,214

4,773

4,826

5,383

9,158

Operating lease liability, net of current portion

1,383

1,501

1,616

1,725

1,882

-

-

-

Liability related to sale of future royalties

99,850

-

-

-

-

-

-

-

Convertible notes (includes $7,937 at December 31, 2017 due to related parties)

-

-

-

-

-

-

41,476

9,921

Redeemable convertible preferred stock warrant liability (includes $1,840 at December 31, 2017 attributable to warrants held by related parties)

-

-

-

-

-

-

5,000

2,300

Derivative instrument (includes $2,467 at September 30, 2018 attributable to related parties)

-

-

-

-

-

-

8,517

-

Other liabilities

288

295

308

317

327

530

552

586

Total liabilities

115,355

13,507

9,225

8,256

6,982

5,356

60,928

21,965

Commitments and contingencies (Note 6)

-

-

-

-

-

-

0

-

Redeemable convertible preferred stock, $0.0001 par value, 10,000,000 and 18,753,595 shares authorized at December 31, 2018 and 2017; 0 and 12,385,154 shares issued and outstanding at December 31, 2018 and 2017; liquidation value of $0 and $50,324 at December 31, 2018 and 2017

-

-

-

-

-

-

50,017

50,017

Stockholders’ equity:
Common stock, $0.0001 par value, 490,000,000 shares authorized at March 31, 2020 and December 31, 2019; 44,452,701 and 44,413,404 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

5

5

4

4

4

4

1

1

Additional paid-in capital

509,716

503,475

202,183

200,138

198,835

197,595

2,273

584

Accumulated other comprehensive income

489

10

19

12

6

-

-

-

Accumulated deficit

-182,523

-158,131

-142,515

-130,135

-118,750

-110,766

-96,104

-69,323

Total stockholders’ equity

327,687

345,359

59,691

70,019

80,095

86,833

-93,830

-68,738

Total liabilities and stockholders’ equity

443,042

358,866

68,916

78,275

87,077

92,189

17,115

3,244